Status
Conditions
Treatments
About
Bioactive fibre-reinforced composite implant is used for reconstruction of skull bone defects and orbital floor defects.
Functional and aesthetic outcome is assessed by patient and doctor.
Full description
Development phase: Clinical trial Objectives: Assessment of functional and aesthetic outcome Methodology: Intervention study Sample size: 35+20+25 Main criteria for inclusion: Skull bone defect OR orbital floor fracture
Investigational drug/treatment, dose and mode of administration: FRC implant Comparative drug(s)/placebo/treatment, dose and mode of administration: -
Duration of treatment: 2 years of follow-up
Assessments:
Clinical outcome and radiologic assesment Functional and aesthetic outcome with Visual Analog Scale (VAS). Pain assessment with VAS.
Statistical methods:
Adequate statistical methods for publishing in international peer-reviewed journals.
Enrollment
Sex
Volunteers
Inclusion criteria
Study arm 1:
Study arm 2:
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
19 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal